{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:54:49Z","timestamp":1791312889327,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chang Jiang Scholar Program","award":["T2017124"],"award-info":[{"award-number":["T2017124"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600197"],"award-info":[{"award-number":["81600197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Foundation of the First Affiliated Hospital of Dalian Medical University","award":["2017D044"],"award-info":[{"award-number":["2017D044"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.lfs.2019.04.044","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:18:04Z","timestamp":1555543084000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo"],"prefix":"10.1016","volume":"227","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.04.044_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2019.04.044_bb0010","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016[J]","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2019.04.044_bb0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2015.133","article-title":"Cardiotoxicity of anticancer treatments[J]","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities[J]","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0025","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect[J]","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2019.04.044_bb0030","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1074\/jbc.M107442200","article-title":"Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism[J]","volume":"277","author":"Lorenzo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.04.044_bb0035","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity[J]","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2019.04.044_bb0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1159\/000323984","article-title":"Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats--species differences and technical considerations[J]","volume":"26","author":"Nowik","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2019.04.044_bb0045","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000087592.47401.37","article-title":"Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells[J]","volume":"108","author":"Nishimura","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.04.044_bb0050","doi-asserted-by":"crossref","first-page":"H1120","DOI":"10.1152\/ajpheart.00173.2006","article-title":"Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction[J]","volume":"292","author":"Aber","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0055","doi-asserted-by":"crossref","first-page":"L875","DOI":"10.1152\/ajplung.00293.2011","article-title":"Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension[J]","volume":"302","author":"Christou","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2019.04.044_bb0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced cardiomyopathy[J]","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.04.044_bb0065","first-page":"827","article-title":"Adriamycin cardiotoxicity: a survey of 1273 patients[J]","volume":"63","author":"Praga","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.lfs.2019.04.044_bb0070","first-page":"1789","article-title":"Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis[J]","volume":"60","author":"Arola","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.04.044_bb0075","first-page":"183","article-title":"Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management[J]","volume":"60","author":"Palazzuoli","year":"2012","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/mmr.2013.1554","article-title":"Activation of the p38 MAPK\/NF-kappaB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells[J]","volume":"8","author":"Guo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2019.04.044_bb0085","doi-asserted-by":"crossref","first-page":"25374","DOI":"10.1074\/jbc.M115.667162","article-title":"Acid-dependent Interleukin-1 (IL-1) cleavage limits available pro-IL-1beta for caspase-1 cleavage[J]","volume":"290","author":"Edye","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.04.044_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1159\/000430222","article-title":"Inhibitory effect of NH4Cl treatment on renal Tgfss1 signaling following unilateral ureteral obstruction[J]","volume":"37","author":"Feger","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2019.04.044_bb0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcp.2014.01.040","article-title":"Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK[J]","volume":"88","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FJC.0b013e318291c094","article-title":"Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes[J]","volume":"62","author":"An","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2019.04.044_bb0105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1046\/j.1523-1755.1998.00952.x","article-title":"Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH[J]","volume":"53","author":"Ling","year":"1998","journal-title":"Kidney Int."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2019.04.044_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj2950011","article-title":"Effect of cell volume on Acridine Orange fluorescence in hepatocytes[J]","volume":"295","author":"Volkl","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2019.04.044_bb0115","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11064-012-0777-2","article-title":"Transporters and channels in cytotoxic astrocyte swelling[J]","volume":"37","author":"Pasantes-Morales","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2019.04.044_bb0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1152\/physrev.1981.61.2.296","article-title":"Intracellular pH[J]","volume":"61","author":"Roos","year":"1981","journal-title":"Physiol. Rev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519303066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519303066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:19:48Z","timestamp":1758399588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519303066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":24,"alternative-id":["S0024320519303066"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.04.044","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}